Posttranslational Modification of 6-Phosphofructo-1-Kinase in Cancer Metabolism
Author Information
Author(s): Šmerc Andreja, Sodja Eva, Legiša Matic
Primary Institution: Department of Biotechnology, National Institute of Chemistry, Ljubljana, Slovenia
Hypothesis
The study investigates whether posttranslational modification of 6-phosphofructo-1-kinase (PFK1) is a key factor in the deregulation of glycolytic flux in tumors.
Conclusion
The study concludes that posttranslational modification of PFK1 may significantly contribute to the altered glycolytic metabolism observed in cancer cells.
Supporting Evidence
- Active shorter PFK1 fragments were detected in tumorigenic cell lines but not in non-tumorigenic cells.
- PFK1 activity was preserved after posttranslational modification, indicating functional changes.
- Transfected cells expressing modified PFK1 fragments showed increased glucose consumption and lactate production.
Takeaway
Cancer cells change how they use sugar to grow faster, and this study found that a specific enzyme involved in sugar processing is modified in a way that helps cancer cells thrive.
Methodology
The study involved isolating PFK1 from rabbit muscle, performing limited proteolysis, and analyzing the resulting fragments in various cell lines and conditions.
Limitations
The exact protease responsible for the posttranslational modifications in human cells remains unidentified.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website